Skip to Main Content

Author Details

Xinghai Li
Duke University
2009
33
21
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36630826An injectable PEG-like conjugate forms a subcutaneous depot and enables sustained delivery of a peptide drug.Biomaterials2023
35077742Intratumoral delivery of brachytherapy and immunotherapy by a thermally triggered polypeptide depot.J Control Release2022
35839459Genetically Engineered Nanoparticles of Asymmetric Triblock Polypeptide with a Platinum(IV) Cargo Outperforms a Platinum(II) Analog and Free Drug in a Murine Cancer Model.Nano Lett2022
35668193P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.Nat Cancer2022
35860249Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation.Front Immunol2022
35960413HC-1119, a deuterated Enzalutamide, inhibits Migration, Invasion and Metastasis of the AR-positive triple-negative breast Cancer cells.Mol Biol Rep2022
36261625Brachytherapy via a depot of biopolymer-bound <sup>131</sup>I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours.Nat Biomed Eng2022
35133079Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart.Adv Sci (Weinh)2022
32125864Genetically Encoded Stealth Nanoparticles of a Zwitterionic Polypeptide-Paclitaxel Conjugate Have a Wider Therapeutic Window than Abraxane in Multiple Tumor Models.Nano Lett2020
30504081Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery.Biomaterials2019
31642326Heuristics for the Optimal Presentation of Bioactive Peptides on Polypeptide Micelles.Nano Lett2019
31517048Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models.Sci Adv2019
30756483Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin.Small2019
29146246Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity.J Control Release2018
30461287Genetically Encoding Albumin Binding into Chemotherapeutic-loaded Polypeptide Nanoparticles Enhances Their Antitumor Efficacy.Nano Lett2018
28828438Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth.Nanoscale2017
30319320Encapsulating a Hydrophilic Chemotherapeutic into Rod-like Nanoparticles of a Genetically Encoded Asymmetric Triblock Polypeptide Improves its Efficacy.Adv Funct Mater2017
29062587One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer.Nat Biomed Eng2017
27111757Developing Precisely Defined Drug-Loaded Nanoparticles by Ring-Opening Polymerization of a Paclitaxel Prodrug.Adv Healthc Mater2016
28989813A brush-polymer conjugate of exendin-4 reduces blood glucose for up to five days and eliminates poly(ethylene glycol) antigenicity.Nat Biomed Eng2016
27439953A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics.Angew Chem Int Ed Engl2016
26928529Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy.J Control Release2016
26702586Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor.Biomaterials2016
25427831Ring-opening polymerization of prodrugs: a versatile approach to prepare well-defined drug-loaded nanoparticles.Angew Chem Int Ed Engl2015
26481301Site-Specific Zwitterionic Polymer Conjugates of a Protein Have Long Plasma Circulation.Chembiochem2015
26239362A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models.Nat Commun2015
25637704Doxorubicin-conjugated polypeptide nanoparticles inhibit metastasis in two murine models of carcinoma.J Control Release2015
24738626Rational design of "heat seeking" drug loaded polypeptide nanoparticles that thermally target solid tumors.Nano Lett2014
23359691Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control.Proc Natl Acad Sci U S A2013
23928357A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection.J Control Release2013
22417133Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution.Nano Lett2012
23155121Brachytherapy using injectable seeds that are self-assembled from genetically encoded polypeptides in situ.Cancer Res2012
18620751Altered stored calcium release in skeletal myotubes deficient of triadin and junctin.Cell Calcium2009
  • 1 - 33 of 33

Recommended Authors

Ottawa Hospital Research Institute
Career Start Year 2015
Number of shared co-authors 0
The Second Hospital of Dalian Medical University
Career Start Year 2010
Number of shared co-authors 0
Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University
Career Start Year 2010
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
University of Pittsburgh School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.
Career Start Year 2008
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
Leiden Institute of Chemistry, Leiden University
Career Start Year 2007
Number of shared co-authors 0
Guizhou University of Traditional Chinese Medicine
Career Start Year 2004
Number of shared co-authors 0
Institute of Molecular and Cell Biology
Career Start Year 2004
Number of shared co-authors 0
The University of Texas M.D. Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 0
The Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Duke University
Career Start Year 2003
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 2002
Number of shared co-authors 0
University Health Network
Career Start Year 2001
Number of shared co-authors 0
Massachusetts General Hospital, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 0
Institute for Stem Cell Science and Regenerative Medicine (InStem)
Career Start Year 1998
Number of shared co-authors 0
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Yale University
Career Start Year 1996
Number of shared co-authors 0
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1994
Number of shared co-authors 0
Duke University
Career Start Year 1994
Number of shared co-authors 0
Institute of Materials Research and Engineering
Career Start Year 1993
Number of shared co-authors 0
Stanford University
Career Start Year 1993
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1990
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey
Career Start Year 1988
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
Rutgers Cancer Institute of New Jersey
Career Start Year 1983
Number of shared co-authors 1
Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences
Career Start Year 1969
Number of shared co-authors 2

Collaborators

Duke University
Co-authored papers 30
Duke University
Co-authored papers 2
Duke University
Co-authored papers 2
Universite de Paris, INSERM, CNRS
Co-authored papers 1
Co-authored papers 1
Duke University
Co-authored papers 1
Universite Cote d'Azur, INSERM U5
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Duke University
Co-authored papers 1
Universite de Paris, INSERM, CNRS
Co-authored papers 1
Universite de Paris, Inserm CIC 1427
Co-authored papers 1
Duke University Medical Center
Co-authored papers 1
Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard
Co-authored papers 1
Duke University School of Medicine Durham
Co-authored papers 1
Duke University School of Medicine
Co-authored papers 1
Universite de Paris, INSERM, CNRS
Co-authored papers 1
Duke University
Co-authored papers 1
Duke University
Co-authored papers 1
Universite Paris Cite, INSERM, CNRS
Co-authored papers 1
Duke University
Co-authored papers 1
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers 1
Duke University
Co-authored papers 1
Universite Cote d'Azur, INSERM U5
Co-authored papers 1
Universite de Paris, INSERM, CNRS
Co-authored papers 1
Universite Cote d'Azur, Institut National de la Sante et de la Recherche Medicale
Co-authored papers 1
Peking University People's Hospital
Co-authored papers 1
Duke University
Co-authored papers 1
Universite de Paris, INSERM, CNRS
Co-authored papers 1